(Q30784418)

26 June 2017

1 reference

title

Dynamic susceptibility contrast MRI of gliomas (English)

1 reference

magnetic resonance imaging

26 June 2017

0 references

author name string

Hannu J Aronen

series ordinal

1

1 reference

PubMed ID

12687908

26 June 2017

Jussi Perkiö

series ordinal

2

1 reference

26 June 2017

1 November 2002

1 reference

Neuroimaging clinics of North America

26 June 2017

1 reference

26 June 2017

12

1 reference

26 June 2017

4

1 reference

26 June 2017

501-523

1 reference

Tumor angiogenesis: therapeutic implications

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Prognostic significance of endothelial surface score and MIB-1 labeling index in glioblastoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Prognostic significance of the endothelial surface in low-grade resected oligodendrogliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Relation of neovascularisation to metastasis of non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Angiogenesis is an independent prognostic factor in malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Angiogenic Activity as a Marker of Neoplastic and Preneoplastic Lesions of the Human Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Quantification of angiongenesis as an independent predictor of prognosis in invasive bladder carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Tumor angiogenesis: an independent prognostic parameter in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Perfusion imaging with NMR contrast agents

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Functional mapping of the human visual cortex by magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Susceptibility contrast imaging of cerebral blood volume: human experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Functional cerebral imaging by susceptibility-contrast NMR.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Contrast agents and cerebral hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Multi-planar image formation using NMR spin echoes

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Real-time echo-planar imaging by NMR

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

On the theory of the indicator-dilution method for measurement of blood flow and volume

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Contrast-to-noise ratio in functional MRI of relative cerebral blood volume with sprodiamide injection.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Microscopic susceptibility variation and transverse relaxation: theory and experiment.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

MR contrast due to intravascular magnetic susceptibility perturbations

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Perfusion MRI of the human brain with dynamic susceptibility contrast: gradient-echo versus spin-echo techniques

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

NMR imaging of changes in vascular morphology due to tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Utility of simultaneously acquired gradient-echo and spin-echo cerebral blood volume and morphology maps in brain tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Contrast agents in functional MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Cerebral MR perfusion imaging: first clinical application of a 1 M gadolinium chelate (Gadovist 1.0) in a double-blinded randomized dose-finding study

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Evaluation of four postprocessing methods for determination of cerebral blood volume and mean transit time by dynamic susceptibility contrast imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Signal-to-noise analysis of cerebral blood volume maps from dynamic NMR imaging studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Researches on the Circulation Time in Organs and on the Influences which affect it: Parts I.-III

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time?

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part II: Experimental comparison and preliminary results.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Evaluation of the ratio of cerebral blood flow to cerebral blood volume as an index of local cerebral perfusion pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Cerebrovascular dynamics of autoregulation and hypoperfusion. An MRI study of CBF and changes in total and microvascular cerebral blood volume during hemorrhagic hypotension

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Modeling cerebral blood flow and flow heterogeneity from magnetic resonance residue data

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Combined diffusion-weighted and perfusion-weighted flow heterogeneity magnetic resonance imaging in acute stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

On the oxygenation of hemoglobin in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Cerebral blood flow measurements by magnetic resonance imaging bolus tracking: comparison with [(15)O]H2O positron emission tomography in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Absolute cerebral blood flow and blood volume measured by magnetic resonance imaging bolus tracking: comparison with positron emission tomography values

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Brain tumors. Part 2.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Preclinical MRI experience in imaging angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Grading of astrocytomas. A simple and reproducible method.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

The new WHO classification of brain tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Gliomas: classification with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

MRI enhancement and microvascular density in gliomas. Correlation with tumor cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

1 reference

7 January 2021

Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Tumor vascularity in the brain: evaluation with dynamic susceptibility-contrast MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Dynamic contrast-enhanced magnetic resonance imaging as a surrogate marker of tumor response to anti-angiogenic therapy in a xenograft model of glioblastoma multiforme

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Early changes measured by magnetic resonance imaging in cerebral blood flow, blood volume, and blood-brain barrier permeability following dexamethasone treatment in patients with brain tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Functional cerebral imaging in the evaluation and radiotherapeutic treatment planning of patients with malignant glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Positron emission tomography in patients with glioma. A predictor of prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Differentiation of cerebral radiation necrosis from tumor recurrence by [18F]FDG and 82Rb positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Cerebral necrosis after radiotherapy and/or intraarterial chemotherapy for brain tumors: PET and neuropathologic studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

FDG-PET in the selection of brain lesions for biopsy.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Positron emission tomography in the detection of malignant degeneration of low-grade gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

MR imaging of tumor microcirculation: promise for the new millennium.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Pre-operative grading of intracranial glioma.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Effect of radiation on blood volume in low-grade astrocytomas and normal brain tissue: quantification with dynamic susceptibility contrast MR imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

Challenges for imaging angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1052-5149%2802%2900026-6

7 January 2021

10.1016/S1052-5149(02)00026-6

Identifiers

DOI

1 reference

26 June 2017

1 reference

PubMed ID

12687908